Clinical Trial Update: Safety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder Tumors [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety, dose tolerance, pharmacokinetics, and pharmacodynamics of CPX-POM in patients with bladder tumors; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• CPX-POM

Snippet

Sponsor: CicloMed LLC | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-06-18